mechlorethamine has been researched along with Leucocythaemia in 184 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 9.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| "Among these, leukemia is extremely common, and thus, developing novel drugs to combat leukemia is crucial." | 5.72 | Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx. ( Chen, H; Cui, J; Dai, T; Lin, L; Liu, Y; Lu, W; Sun, D; Yang, L; Yang, X, 2022) |
| "In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine." | 5.08 | Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997) |
| " Patients were randomized in the Southwest Oncology Group (later the Pediatric Oncology Group [POG] to involved-field (IF) radiotherapy alone or IF radiotherapy followed by six courses of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) chemotherapy; patients in the Children's Cancer Study Group (CCSG) and Cancer and Leukemia Group B (CALGB) were randomized to receive extended-field (EF) radiotherapy or IF radiotherapy followed by six courses of MOPP." | 5.06 | The intergroup Hodgkin's disease in children. A study of stages I and II. ( Fryer, C; Fuller, LM; Gehan, EA; Gilchrist, GS; Hanson, W; Hays, DM; Heller, R; Johnston, J; Kennedy, P; Sullivan, MP, 1990) |
| " After a median follow-up of more than 6 years following MOPP (mechlorethamine/vincristine/procarbazine/prednisone) chemotherapy with or without radiotherapy, 5% of patients with Hodgkin's disease developed second primaries, 60% of which were leukemias." | 4.78 | Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects. ( Petru, E; Schmähl, D, 1991) |
| " The risk of treatment-induced acute leukemias as well as sterility can be avoided or greatly decreased with drug combinations not including procarbazine HCI and alkylating agents." | 4.77 | Chemotherapy of malignant lymphomas. ( Bonadonna, G, 1985) |
| "In addition to mechlorethamine, lomustine and teniposide combinations were also linked to an elevated risk of developing leukemia." | 3.69 | Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. ( Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE, 1994) |
| " Human chronic myelogenous leukemia K-562 cells were efficiently transduced with the N2Yc retrovirus vector and showed a significant increase in the 50% inhibitory concentration of chlorambucil (3." | 3.69 | Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells. ( Cournoyer, D; Greenbaum, M; Letourneau, S, 1996) |
| "The effect of morphine and cocaine on the transport of hydrolyzed nitrogen mustard (NH2-OH) and choline by peripheral blood cells of normal subjects and patients with chronic lymphocytic leukemia, acute lymphoblastic leukemia, and acute myeloblastic leukemia was determined." | 3.65 | Drug-induced stimulation of transport of hydrolyzed nitrogen mustard and choline by normal and leukemic human cells in vitro. ( Goldenberg, GJ, 1976) |
| "Cancer is considered one of the gruelling challenges and poses a grave health hazard across the globe." | 2.82 | Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy. ( Karati, D; Kumar, D; Mahadik, KR; Trivedi, P, 2022) |
| "Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches." | 2.37 | Early-stage Hodgkin's disease: current approaches to treatment. ( MacKenzie, R; Rusthoven, JJ, 1985) |
| "The prognosis of patients with Hodgkin's disease has dramatically improved over the past few decades." | 2.37 | Current management of Hodgkin's disease. ( Behrens, BC; DeVita, VT; Young, RC, 1985) |
| "Among these, leukemia is extremely common, and thus, developing novel drugs to combat leukemia is crucial." | 1.72 | Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx. ( Chen, H; Cui, J; Dai, T; Lin, L; Liu, Y; Lu, W; Sun, D; Yang, L; Yang, X, 2022) |
| "Concerning ANLL, the MOPP regimen was significantly associated with a higher risk: 3." | 1.31 | Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. ( Andrieu, JM; Colonna, P; Delwail, V; Jais, JP, 2002) |
| "Patients treated for Hodgkin's disease have an increased risk of developing subsequent acute leukemia." | 1.30 | The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con ( Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M, 1998) |
| " All other disease stages will require a different strategy that should consist of radiotherapy combined with short-term effective regimens, such as ABVD (doxorubicin, bleomycin, vinblastine and decarbazine) or VBM (vinblastine, bleomycin and methotrexate) to reduce the incidence of MOPP-associated gonadal dysfunction and leukaemogenesis." | 1.28 | Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. ( Banfi, A; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Tesoro Tess, JD; Valagussa, P; Viviani, S; Zanini, M; Zucali, R, 1992) |
| "3 microM, ethacrynic acid was toxic to 8 of 24 (33%) tumor specimens studied." | 1.28 | Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues. ( Kern, DH; Messenger, JC; Nagourney, RA; Weisenthal, LM, 1990) |
| "Thirty-four subsequent second malignant neoplasms were observed in 33 patients among those treated for Hodgkin's disease." | 1.27 | Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. ( DeVita, VT; Glatstein, E; Kelley, PA; Kinsella, TJ; Makuch, RW; Tester, WJ; Waller, B, 1984) |
| "Patients who had a relapse of Hodgkin's disease did not have an increased incidence of second malignancy." | 1.27 | Second malignancy complicating Hodgkin's disease. ( Mercier, JP; Tawil, E, 1983) |
| "Menadiol was tested alone and in combination with standard antineoplastic agents." | 1.27 | Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms. ( Dill, PL; Duarte, TE; Su, YZ; Weisenthal, LM, 1987) |
| "Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic abnormalities of the bone marrow." | 1.27 | Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. ( Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM, 1985) |
| "Stage II Hodgkin's disease probably should be divided into two substages requiring different treatment." | 1.26 | [The current state of curability of Hodgkin's disease]. ( Streuli, RA; Ultmann, JE, 1981) |
| "We studied 680 patients with Hodgkin's disease, treated at Stanford University Medical Center from July 1, 1968, through December 31, 1975, to determine the risk of development of hematologic neoplasia." | 1.26 | Hematologic neoplasia in patients treated for Hodgkin's disease. ( Coleman, CN; Flint, A; Glatstein, EJ; Kaplan, HS; Rosenberg, SA; Williams, CJ, 1977) |
| "Urethane is the best treatment available for multiple myeloma." | 1.23 | New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 165 (89.67) | 18.7374 |
| 1990's | 14 (7.61) | 18.2507 |
| 2000's | 3 (1.63) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (1.09) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, T | 1 |
| Lin, L | 1 |
| Chen, H | 1 |
| Lu, W | 1 |
| Yang, X | 1 |
| Yang, L | 1 |
| Liu, Y | 1 |
| Cui, J | 1 |
| Sun, D | 1 |
| Karati, D | 1 |
| Mahadik, KR | 1 |
| Trivedi, P | 1 |
| Kumar, D | 1 |
| ERSLEV, A | 1 |
| WINTROBE, MM | 4 |
| HUGULEY, CM | 3 |
| BURCHENAL, JH | 5 |
| LESTER, RA | 1 |
| GOODMAN, LS | 2 |
| SYKES, MP | 1 |
| IRWIN, GE | 1 |
| MARLOW, AA | 1 |
| BARTLETT, GR | 1 |
| RUNDLES, RW | 1 |
| BARTON, WB | 1 |
| COONRAD, EV | 1 |
| KLIMA, R | 1 |
| HORNISCHER, R | 1 |
| HOLY, J | 1 |
| SUCHAN, M | 1 |
| MORELLI, A | 1 |
| MAUREA, C | 1 |
| KUROYANAGI, S | 1 |
| INTROZZI, P | 2 |
| MARINONE, G | 2 |
| HOLTHAUS, JM | 1 |
| BEATTIE, JW | 1 |
| HOWELLS, LH | 1 |
| CAKMAKCI, A | 1 |
| RAMIOUL, H | 1 |
| TOKUOKA, S | 1 |
| SELLEI, C | 2 |
| ECKHARDT, S | 2 |
| HARTAI, F | 1 |
| DUMBOVICH, B | 1 |
| BERNARD, J | 2 |
| MATHE, G | 2 |
| WEIL, M | 3 |
| HANSEN, PB | 1 |
| HORLIN, W | 1 |
| SCHMITT, W | 1 |
| HELLENDOORN, HB | 1 |
| PELT, M | 1 |
| GERBRANDY, J | 1 |
| LAMY, P | 1 |
| REMIGY, E | 1 |
| STEHLIN, H | 1 |
| KRAKOFF, IH | 1 |
| KARNOFSKY, DA | 2 |
| ZULIK, R | 1 |
| LOVISETTO, P | 1 |
| CASTELLANO, M | 1 |
| SCHREK, R | 2 |
| FRIEDMAN, IA | 1 |
| LEITHOLD, L | 1 |
| SZENTKLARAY, J | 1 |
| CHILOV, K | 2 |
| IVANOV, S | 2 |
| KIRCHEV, P | 1 |
| BLOCK, M | 2 |
| MOKEEVA, RA | 1 |
| VISHNIAKOVA, EG | 1 |
| DIAMOND, HD | 1 |
| DOAN, CA | 1 |
| WISEMAN, BK | 1 |
| BOURONCLE, BA | 1 |
| LAWKOWICZ, W | 1 |
| BECALSKI, J | 1 |
| BARLOW, AM | 1 |
| LEEMING, JT | 1 |
| WILKINSON, JF | 3 |
| GALTON, DA | 1 |
| WILTSHAW, E | 1 |
| SZUR, L | 1 |
| DACIE, JV | 1 |
| PISANI, A | 2 |
| POGGI, C | 2 |
| MEARDI, G | 2 |
| ARMAGHAN, V | 1 |
| GERHARTZ, H | 1 |
| WIEDEMANN, H | 1 |
| SPRAGUE, CC | 1 |
| THEOLOGIDES, A | 1 |
| KENNEDY, BJ | 1 |
| HARRINGTON, WJ | 2 |
| HALLORAN, MJ | 1 |
| KIRCHOFF, VG | 1 |
| REINHARD, EH | 1 |
| GROSSMAN, R | 1 |
| WHITE, B | 1 |
| HILGER, E | 1 |
| SAMPEY, JR | 6 |
| KOJIMA, M | 1 |
| NAKAMOTO, S | 1 |
| KOLFF, WJ | 1 |
| EVANS, AM | 1 |
| RIEKHOF, P | 1 |
| IMAMURA, S | 1 |
| NAKAKUKI, K | 1 |
| KATCHMAN, BJ | 1 |
| ZIPF, RE | 1 |
| MURPHY, JP | 1 |
| JEN, YF | 1 |
| STEFANI, S | 1 |
| DOCTOR, VM | 1 |
| DE BERGSAGEL, DE | 1 |
| SHULLENBERGER, CC | 1 |
| ADAMS, JL | 1 |
| MATSUOKA, M | 1 |
| CREPALDI, G | 1 |
| PARPAJOLA, A | 1 |
| BURNINGHAM, RA | 1 |
| RESTREPO, A | 1 |
| PUGH, RP | 1 |
| BROWN, EB | 1 |
| SCHLOSSMAN, SF | 1 |
| KHURI, PD | 1 |
| LESSNER, HE | 1 |
| DIAMANDOPOULOS, GT | 1 |
| SMITH, EB | 1 |
| DUNNING, WF | 1 |
| CURTIS, MR | 1 |
| DOWD, JE | 1 |
| DIPAOLO, JA | 1 |
| WATNE, AL | 1 |
| IRIARTE, P | 1 |
| JAGASIA, H | 1 |
| THURMAN, WG | 2 |
| FRIEDMAN, OM | 1 |
| BOGER, E | 1 |
| GRUBLIAUSKAS, V | 1 |
| SOMMER, H | 1 |
| HUTCHISON, JL | 1 |
| TSOU, KC | 1 |
| SU, HC | 1 |
| CORREA, JN | 1 |
| ANDREWS, JR | 1 |
| DUHIG, JT | 1 |
| KEIDAN, SE | 1 |
| MAINWARING, D | 1 |
| SMITH, JC | 1 |
| BOLANDE, RP | 1 |
| CONKLIN, JW | 1 |
| UPTON, AC | 1 |
| CHRISTENBERRY, KW | 1 |
| GREEN, RA | 1 |
| DIXON, H | 1 |
| MORROW, LB | 1 |
| ANDERSON, RE | 1 |
| VESIN, S | 1 |
| LIBANSKY, J | 1 |
| CHUDOMEL, V | 1 |
| BRABEC, V | 1 |
| SOCHMAN, J | 1 |
| SANDOR, L | 1 |
| CERNY, V | 1 |
| UJHAZY, V | 1 |
| WINKLER, A | 1 |
| NEMETH, L | 1 |
| GAL, F | 1 |
| PORTER, FS | 1 |
| HOLOWACH, J | 1 |
| RUNDLES, W | 1 |
| GRIZZLE, J | 1 |
| BONO, VH | 1 |
| JONSSON, U | 1 |
| CORLEY, CC | 1 |
| WEICKER, H | 1 |
| LINDEMANN, M | 1 |
| GUMMEL, H | 1 |
| GARDIKAS, C | 2 |
| BURCHENAL, JR | 1 |
| JOHNSTON, SF | 1 |
| SIEBEROVA-KLIMOVA, R | 1 |
| NINNI, M | 1 |
| LEVI, M | 1 |
| MENE, G | 1 |
| FERRI, A | 1 |
| CAPPELLO, F | 1 |
| de LORENZO, J | 1 |
| JANNINI, P | 1 |
| ABOU SINNA, I | 1 |
| SZREDER, W | 1 |
| MIGDALSKA, Z | 1 |
| KIELER, J | 1 |
| TAZAKI, Y | 1 |
| FUCHIGAMI, A | 1 |
| OOTA, K | 1 |
| INGRASSIA, G | 1 |
| VASILE, B | 1 |
| MELICK, RA | 1 |
| STORTI, E | 1 |
| KEIBL, E | 1 |
| SPITZY, KH | 1 |
| STORCH, L | 1 |
| JANBON, M | 1 |
| BERTRAND, L | 1 |
| PEDERSEN, E | 1 |
| PAVAN, S | 1 |
| MATTHEWS, WB | 1 |
| SPURR, CL | 2 |
| SMITH, TR | 1 |
| JACOBSON, LO | 1 |
| von KRESS, H | 1 |
| Johnson, EP | 1 |
| MYERS, WP | 1 |
| BEN-ASHER, S | 1 |
| LEVIN, WC | 1 |
| HOLT, JG | 1 |
| Valagussa, P | 2 |
| Santoro, A | 3 |
| Fossati Bellani, F | 1 |
| Franchi, F | 1 |
| Banfi, A | 2 |
| Bonadonna, G | 4 |
| Freireich, EJ | 1 |
| Keating, M | 1 |
| Cabanillas, F | 1 |
| Barlogie, B | 1 |
| Dameshek, W | 1 |
| Goodman, MJ | 1 |
| Gilman, A | 1 |
| McLennan, MT | 1 |
| Körbling, M | 1 |
| Hunstein, W | 1 |
| Vorob'ev, AI | 1 |
| Brilliant, MD | 1 |
| Voltarelli, JC | 1 |
| Falcão, RP | 1 |
| Bottura, C | 1 |
| Tester, WJ | 1 |
| Kinsella, TJ | 1 |
| Waller, B | 1 |
| Makuch, RW | 1 |
| Kelley, PA | 1 |
| Glatstein, E | 2 |
| DeVita, VT | 5 |
| Jacquillat, C | 1 |
| Auclerc, G | 1 |
| Auclerc, MF | 1 |
| Maral, J | 1 |
| Tawil, E | 1 |
| Mercier, JP | 1 |
| Aisenberg, AC | 1 |
| Gassmann, W | 1 |
| Schmitz, N | 1 |
| Löffler, H | 1 |
| Gomez, GA | 1 |
| Aggarwal, KK | 1 |
| Han, T | 1 |
| Streuli, RA | 1 |
| Ultmann, JE | 1 |
| Nagourney, RA | 2 |
| Evans, SS | 1 |
| Messenger, JC | 2 |
| Su, YZ | 2 |
| Weisenthal, LM | 3 |
| van Leeuwen, FE | 1 |
| Chorus, AM | 1 |
| van den Belt-Dusebout, AW | 1 |
| Hagenbeek, A | 2 |
| Noyon, R | 1 |
| van Kerkhoff, EH | 1 |
| Pinedo, HM | 1 |
| Somers, R | 1 |
| Fabbri, S | 1 |
| Prontera, C | 1 |
| Broggini, M | 1 |
| D'Incalci, M | 1 |
| Letourneau, S | 1 |
| Greenbaum, M | 1 |
| Cournoyer, D | 1 |
| Schellong, G | 1 |
| Riepenhausen, M | 1 |
| Creutzig, U | 1 |
| Ritter, J | 1 |
| Harbott, J | 1 |
| Mann, G | 1 |
| Gadner, H | 1 |
| Brusamolino, E | 1 |
| Anselmo, AP | 1 |
| Klersy, C | 1 |
| Santoro, M | 1 |
| Orlandi, E | 1 |
| Pagnucco, G | 1 |
| Lunghi, F | 1 |
| Maurizi-Enrici, R | 1 |
| Baroni, CD | 1 |
| Lazzarino, M | 1 |
| Mandelli, F | 1 |
| Bernasconi, C | 1 |
| Cellai, E | 1 |
| Magrini, SM | 1 |
| Masala, G | 1 |
| Alterini, R | 1 |
| Costantini, AS | 1 |
| Rigacci, L | 1 |
| Olmastroni, L | 1 |
| Papi, MG | 1 |
| Spediacci, MA | 1 |
| Innocenti, F | 1 |
| Bellesi, G | 1 |
| Ferrini, PR | 1 |
| Biti, G | 1 |
| Avilés, A | 3 |
| Neri, N | 1 |
| Delwail, V | 1 |
| Jais, JP | 1 |
| Colonna, P | 1 |
| Andrieu, JM | 1 |
| Garrett, MJ | 1 |
| Das, S | 1 |
| Smith, JD | 1 |
| Freedman, LS | 1 |
| Nissen, NI | 2 |
| Pajak, TF | 1 |
| Glidewell, O | 1 |
| Pedersen-Bjergaard, J | 2 |
| Stutzman, L | 1 |
| Falkson, G | 1 |
| Cuttner, J | 1 |
| Blom, J | 1 |
| Leone, L | 1 |
| Sawitsky, A | 1 |
| Coleman, M | 1 |
| Haurani, F | 1 |
| Harley, JB | 1 |
| Seligman, B | 1 |
| Cornell, C | 1 |
| Henry, P | 1 |
| Senn, HJ | 1 |
| Brunner, K | 1 |
| Martz, G | 1 |
| Maurice, P | 1 |
| Bank, A | 1 |
| Shapiro, L | 1 |
| James, GW | 1 |
| Holland, JF | 1 |
| Coleman, CN | 1 |
| Williams, CJ | 1 |
| Flint, A | 1 |
| Glatstein, EJ | 1 |
| Rosenberg, SA | 1 |
| Kaplan, HS | 1 |
| Goldenberg, GJ | 1 |
| Díaz-Maqueo, JC | 2 |
| Ayala, JR | 1 |
| Cortés, HD | 1 |
| García, EL | 2 |
| Hall, AG | 1 |
| Tilby, MJ | 1 |
| Bonfante, V | 1 |
| Viviani, S | 1 |
| Zucali, R | 1 |
| Devizzi, L | 1 |
| Zanini, M | 1 |
| Tesoro Tess, JD | 1 |
| Kern, DH | 1 |
| Talavera, A | 1 |
| Guzmán, R | 1 |
| Longo, DL | 3 |
| Duffey, PL | 2 |
| Wiernik, PH | 1 |
| Hubbard, SM | 2 |
| Phares, JC | 1 |
| Bastian, AW | 1 |
| Jaffe, ES | 2 |
| Young, RC | 4 |
| Petru, E | 1 |
| Schmähl, D | 1 |
| Gehan, EA | 1 |
| Sullivan, MP | 1 |
| Fuller, LM | 1 |
| Johnston, J | 1 |
| Kennedy, P | 1 |
| Fryer, C | 1 |
| Gilchrist, GS | 1 |
| Hays, DM | 1 |
| Hanson, W | 1 |
| Heller, R | 1 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Sagher, D | 1 |
| Karrison, T | 1 |
| Schwartz, JL | 1 |
| Larson, R | 1 |
| Meier, P | 1 |
| Strauss, B | 1 |
| Ihde, DC | 1 |
| Straus, DJ | 1 |
| Boccaccio, P | 1 |
| Rosa, F | 1 |
| Casciaro, S | 1 |
| D'Elia, P | 1 |
| Romagnoli, M | 1 |
| Ghio, R | 1 |
| España, P | 1 |
| Bonilla, F | 1 |
| Yebra, M | 1 |
| Diego, J | 1 |
| Alvarez de Mon, M | 1 |
| Marazuela, M | 1 |
| Durántez, A | 1 |
| Rowland, KM | 1 |
| Murthy, A | 1 |
| Duarte, TE | 1 |
| Dill, PL | 1 |
| Sizoo, W | 1 |
| Löwenberg, B | 1 |
| Blayney, DW | 1 |
| Greene, MH | 1 |
| Postal, MG | 1 |
| Rusthoven, JJ | 1 |
| MacKenzie, R | 1 |
| Virgolini, L | 1 |
| Behrens, BC | 1 |
| Ersbøll, J | 1 |
| Sørensen, HM | 1 |
| Keiding, N | 1 |
| Larsen, SO | 1 |
| Philip, P | 1 |
| Larsen, MS | 1 |
| Schultz, H | 1 |
| Carbone, PP | 1 |
| Trepel, F | 1 |
| Stockhusen, G | 1 |
| Rastetter, J | 1 |
| Begemann, H | 1 |
| Frei, E | 2 |
| Schabel, FM | 1 |
| Goldin, A | 1 |
| Rubin, P | 1 |
| Pruzanski, W | 1 |
| Saito, S | 1 |
| Benckhuijsen, C | 1 |
| Silber, R | 1 |
| Unger, KW | 1 |
| Ellman, L | 1 |
| Berceanu, S | 1 |
| Gociu, M | 1 |
| Geib, R | 1 |
| Sighetea, E | 1 |
| Dăncescu, I | 1 |
| Segal, E | 1 |
| Tănăsescu, C | 1 |
| Leikin, S | 1 |
| Brubaker, C | 1 |
| Hartmann, J | 1 |
| Murphy, ML | 1 |
| Wolff, J | 1 |
| Fennelly, JJ | 1 |
| Bishop, RC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being[NCT02749474] | 400 participants (Anticipated) | Observational [Patient Registry] | 2003-07-31 | Recruiting | |||
| (PRO#11307) Phase III Randomized Study of Autologous Stem Cell Transplantation With High-dose Melphalan Versus High-dose Melphalan and Bortezomib in Patients With Multiple Myeloma 65 Year or Older[NCT01453088] | Phase 2 | 63 participants (Actual) | Interventional | 2010-06-24 | Terminated (stopped due to Lack of Accrual) | ||
| Tandem Autologous Hematopoietic Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma[NCT01241708] | Phase 3 | 146 participants (Actual) | Interventional | 2010-04-08 | Completed | ||
| A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodg[NCT00479167] | Phase 2 | 1 participants (Actual) | Interventional | 2007-05-31 | Terminated (stopped due to Lack of accrual and interest in study) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01453088)
Timeframe: 1 year
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 27 |
| Auto Transplant High Dose Melphalan+Bortezomib | 27 |
Progression free survival of elderly patients with multiple myeloma treated with either high-dose melphalan versus high-dose melphalan and bortezomib at 3 years (NCT01453088)
Timeframe: Participants will be followed post transplant for a minimum of 3 years, and after that may be monitored as part of the study indefinitely
| Intervention | Participants (Count of Participants) |
|---|---|
| Auto Transplant High Dose Melphalan | 13 |
| Auto Transplant High Dose Melphalan+Bortezomib | 11 |
14 reviews available for mechlorethamine and Leucocythaemia
| Article | Year |
|---|---|
Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy.
Topics: Alkylating Agents; Antineoplastic Agents; Antineoplastic Agents, Alkylating; DNA; Humans; Leukemia; | 2022 |
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxor | 1984 |
In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy.
Topics: Acute Disease; Animals; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Disease Models, | 1984 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; DNA Damage; DNA, Neoplasm; Drug Design; Drug Resi | 1992 |
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod | 1991 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance | 1985 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
Hodgkin's disease: long-term effects of therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Brain; Female; Genitalia, Fem | 1986 |
Early-stage Hodgkin's disease: current approaches to treatment.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem | 1985 |
[Neutrophil leukemia. Review of the literature].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Busulfan; Fema | 1985 |
Current management of Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans; | 1985 |
Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
Topics: Anilides; Animals; Cell Division; Cyclophosphamide; Cytarabine; DNA, Neoplasm; Fluorouracil; Humans; | 1969 |
8 trials available for mechlorethamine and Leucocythaemia
| Article | Year |
|---|---|
ABVD chemotherapy in the treatment of Hodgkin's disease.
Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc | 1982 |
Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug | 1982 |
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 1997 |
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1979 |
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Re | 1991 |
The intergroup Hodgkin's disease in children. A study of stages I and II.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgki | 1990 |
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1988 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
164 other studies available for mechlorethamine and Leucocythaemia
| Article | Year |
|---|---|
Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; DNA Damage; Glutathione Peroxidase | 2022 |
Treatment Of Malignant Blood Diseases and Cancer With Nitrogen Mustard Gas In U.S.A.; Review Article.
Topics: Leukemia; Mechlorethamine | 1948 |
Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Plant; Nitrogen | 1948 |
Studies on the chemotherapy of leukemia; effect of certain nitrogen mustards and carbamates on transmitted mouse leukemia.
Topics: Anti-Anxiety Agents; Carbamates; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1948 |
The newer nitrogen mustards in the treatment of leukemia.
Topics: Ethylamines; Leukemia; Mechlorethamine | 1948 |
Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine | 1947 |
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: Amines; Gas Poisoning; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechloret | 1946 |
Treatment of the leukemias and lymphomas; current trends.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1952 |
Recent advances in treatment of leukemias and lymphomas.
Topics: Humans; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
New therapy for leukemia, polycythemia, and lymphoma.
Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple | 1953 |
The role of chemotherapy in the management of malignant lymphomas and leukemias.
Topics: Adrenocorticotropic Hormone; Cortisone; Disease Management; Folic Acid Antagonists; Humans; Leukemia | 1953 |
[Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
Topics: Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymp | 1953 |
[Therapeutic effect of small doses of chloroethylaminohydrochloride associated with roentgenotherapy in blastomatosis].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Ray Therapy | 1953 |
[Eosinophilic leukemia].
Topics: Adrenocorticotropic Hormone; Hypereosinophilic Syndrome; Leukemia; Mechlorethamine; Nitrogen Mustard | 1953 |
[A case of chronic myelogenous leucaemia treated with nitrogen mustard N-oxide].
Topics: Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Mechlorethamine; Nitr | 1953 |
[Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
Topics: Ethylamines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, | 1953 |
Chemotherapy of lymphomas and leukemia.
Topics: Adrenocorticotropic Hormone; Cortisone; Folic Acid Antagonists; Humans; Leukemia; Lymphoma; Mechlore | 1954 |
Biological actions and therapeutic applications of nitrogen mustard.
Topics: Hodgkin Disease; Leukemia; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitr | 1954 |
[Triethylene melamine treatment of leukemia and lymphogranulomatosis].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis; Triethylenemela | 1954 |
Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia.
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1955 |
[Leukemia-like changes in mice administered with nitrogen mustard N-oxide (nitromin)].
Topics: Animals; Leukemia; Leukemia, Experimental; Mechlorethamine; Mice; Nitrogen Mustard Compounds | 1955 |
Clinical trial of a new nitrogen-mustard compound.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Mechlorethamine; Nitrogen; Nitrogen Mustard Compounds | 1956 |
[Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoid Tiss | 1956 |
Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.
Topics: Chlorambucil; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Mechlorethamine; | 1957 |
[Treatment of hematologic neoplasms with nitrogen oxide mustards].
Topics: Hematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Mechlorethamine; Mustard Plant; Nitrogen | 1957 |
[Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1957 |
[Biochemical changes in induced cytolysis].
Topics: Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Radiotherapy | 1957 |
[Severe terminal purpura during CB 1348 therapy of chronic lymphoid leukemia].
Topics: Chlorambucil; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Mechlorethamine; | 1957 |
Remissions induced by chlorambucil in chronic granulocytic leukemia.
Topics: Chlorambucil; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mechlorethamine; Neoplasms | 1958 |
[Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustar | 1958 |
[P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret | 1958 |
Variability of the in vitro sensitivity of human leukemic lymphocytes to x-rays and chemotherapeutic agents.
Topics: Humans; In Vitro Techniques; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mechlorethamine; Nitrogen Mu | 1958 |
[Therapeutic procedures for ambulatory treatment of hemoblastosis and malignant neoplasms].
Topics: Ascorbic Acid; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Vitamin A | 1958 |
[Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds].
Topics: Antineoplastic Agents; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compo | 1957 |
Histopathologic effects of x-rays, radiophosphorus, nitrogen mustard, urethane, and steroids upon the spleen in leukemias and lymphomas.
Topics: Adrenocorticotropic Hormone; Cortisone; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compou | 1958 |
[Result of use of dopan in treatment of chronic myeloleukosis].
Topics: Humans; Leukemia; Leukemia, Myeloid; Mechlorethamine; Nitrogen Mustard Compounds; Uracil; Uracil Mus | 1958 |
[Lymphoid leukemia treated by the combination of cortisone, CB 1348 & transfusions].
Topics: Blood Transfusion; Chlorambucil; Cortisone; Leukemia; Leukemia, Lymphoid; Mechlorethamine; Nitrogen | 1958 |
[First results of dopane therapy of chronic myeloid leukemia and of certain malignant tumors].
Topics: Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Mechlorethami | 1958 |
Clinical indications for the use of nitrogen mustard and triethylene melamine in malignant lymphomas and leukemias.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine | 1958 |
Clinical evaluation of CB 1348 in leukemias and lymphomas.
Topics: Chlorambucil; Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds | 1958 |
[Observations on the application of CB-1348 in lymphatic leukemias].
Topics: Chlorambucil; Humans; Leukemia; Leukemia, Lymphoid; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
Topics: Leukemia; Mannitol; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Polycythem | 1959 |
The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia.
Topics: Adrenal Cortex Hormones; Chlorambucil; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leu | 1961 |
[The effect of nitrogen mustard on the oxygen consumption of the leukocytes in chronic myeloid leukemia].
Topics: Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; M | 1960 |
[The effect of nitrogen mustard on the oxygen consumption of the leukocytes in chronic lymphatic leukemia].
Topics: Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes; Mechlorethamine; Nitrogen Must | 1960 |
The effect of mustargen mixed with urethan in the treatment of IRC leukemia in Fischer rats.
Topics: Animals; Leukemia; Leukemia, Experimental; Mechlorethamine; Nitrogen Mustard Compounds; Rats; Rats, | 1961 |
[Alteration of experimental mouse leukemia with nitrogen mustard phosphamide esters].
Topics: Animals; Dimethoate; Esters; Leukemia; Leukemia, Experimental; Mechlorethamine; Mice | 1961 |
[5-year clinical experience with Degranol].
Topics: Leukemia; Mannomustine; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1962 |
Evaluation of the effectiveness of radioactive phosphorus and chlorambucil in patients with chronic lymphocytic leukemia.
Topics: Chlorambucil; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphocytes; Mec | 1962 |
Effect of uracil mustard in malignant lymphoma and chronic lymphatic leukemia.
Topics: Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Minnesota; Nitrogen Mustard Compounds; Urac | 1962 |
Some immunologic aspects of the evolution and treatment of leukemia.
Topics: Animals; Biological Products; Busulfan; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compound | 1962 |
[Forms of leukosis and their therapy].
Topics: Adrenocorticotropic Hormone; Antineoplastic Agents; Busulfan; Colchicine; Folic Acid Antagonists; Go | 1963 |
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. IX. Further clinical reports, 1960-1962.
Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1963 |
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. VII. Clinical reports, 1959-62.
Topics: Disease Management; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1962 |
[TUMOR-FORMING LEUKEMIA (INCLUDING CHLOROMA)].
Topics: Adolescent; Alanine; Antineoplastic Agents; Child; Dexamethasone; Humans; Leukemia; Mechlorethamine; | 1963 |
THE URIC ACID ANURIA OF LEUKEMIA TREATED BY DIALYSIS.
Topics: Adolescent; Anuria; Chlorambucil; Fluid Therapy; Humans; Kidney; Kidneys, Artificial; Leukemia; Mech | 1963 |
LEUKEMIA. AN ANALYSIS OF 209 CASES FROM THE ELLIS FISCHEL STATE CANCER HOSPITAL.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Busulfan; Cancer Care Facilit | 1963 |
[A CASE OF LEUKEMIA CUTIS].
Topics: Dactinomycin; Dermatology; Humans; Leukemia; Mechlorethamine; Pathology; Prednisolone; Skin; Skin Ne | 1963 |
THE EFFECT OF CHEMOTHERAPEUTIC AGENTS UPON THE METABOLISM OF INTACT HUMAN CANCER CELLS: AN IN VITRO TECHNIC FOR CELL SENSITIVITY.
Topics: Aminopterin; Antineoplastic Agents; Azaguanine; Carbohydrate Metabolism; In Vitro Techniques; Lactat | 1963 |
[TUMOUR CHEMOTHERAPY. IX. NITROGEN MUSTARDS OF PHOSPHORAMIDE, PHOSPHORAMIDE ESTER AND THIOESTER].
Topics: Animals; Fibrosarcoma; Leukemia; Leukemia, Experimental; Mechlorethamine; Mice; Neoplasms; Nitrogen | 1962 |
RESISTANCE OF PHYTOHAEMAGGLUTININ-TREATED LYMPHOCYTES TO X-RAYS AND NITROGEN MUSTARD.
Topics: Antibodies; Biochemical Phenomena; Humans; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mechlorethamin | 1963 |
EFFECT OF ADMINISTRATION OF ALKYLATING AGENTS OR 6-MERCAPTOPURINE ON SERUM LEVEL OF DEOXYRIBONUCLEASE I IN LEUKEMIA PATIENTS.
Topics: Alkylating Agents; Blood Chemical Analysis; Busulfan; Deoxyribonuclease I; DNA; Humans; Leukemia; Le | 1963 |
CHRONIC LYMPHATIC LEUKAEMIA AND ITS MANAGEMENT.
Topics: Adrenal Cortex Hormones; Chlorambucil; Geriatrics; Humans; Leukemia; Leukemia, Lymphoid; Mechloretha | 1963 |
[IMPROVEMENT AND EXACERBATION IN LEUKEMIA].
Topics: Aminocaproates; Aminocaproic Acid; Anemia; Antineoplastic Agents; Blood Transfusion; Busulfan; Centr | 1963 |
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky | 1964 |
WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS.
Topics: Anemia; Anemia, Hemolytic; Betamethasone; Chlorambucil; Dexamethasone; Geriatrics; Humans; Leukemia; | 1964 |
PHAGOCYTOSIS IN RETICULUM CELL SARCOMA.
Topics: Adolescent; Black People; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Leukemia; | 1964 |
COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
Topics: Animals; Benzaldehydes; Carcinoma, Bronchogenic; Carcinoma, Hepatocellular; Female; Humans; Injectio | 1964 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop | 1964 |
LYMPHANGIOGRAPHY FOR MALIGNANT DISEASES IN CHILDREN.
Topics: Adolescent; Child; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Myeloid; Lymph Nodes; Lympha | 1964 |
SYNTHESIS OF N-PHOSPHORYLATED DERIVATIVES OF NITROGEN MUSTARDS WITH LATENT CYTOTOXICITY.
Topics: Animals; Chemistry, Pharmaceutical; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymp | 1963 |
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Human | 1964 |
SYNTHESIS OF POSSIBLE CANCER CHEMOTHERAPEUTIC COMPOUNDS BASED ON ENZYME APPROACH. V. TETRAZOLIUM NITROGEN MUSTARDS.
Topics: Animals; Carcinoma; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Leukemia; Leukemia, Experiment | 1963 |
MODIFICATION OF THE RADIATION EFFECT ON ASCITIC TUMOUR CELLS BY PHARMACOLOGICAL AGENTS INJECTED INTRAVENOUSLY.
Topics: beta-Aminoethyl Isothiourea; Glutathione; Injections; Injections, Intravenous; Leukemia; Leukemia, E | 1964 |
TUMOR INCIDENCE IN A-STRAIN MICE.
Topics: Cyclophosphamide; Incidence; Leukemia; Leukemia, Radiation-Induced; Lung Neoplasms; Mechlorethamine; | 1965 |
ASSOCIATION OF HERPES ZOSTER WITH LEUKEMIA AND LYMPHOMA IN CHILDREN.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Child; Cyclophosphamide; Drug Therapy; Herpes Zoster; Ho | 1965 |
RADIATION AND DRUG INDUCED HYALINIZATION OF THE STOMACH.
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Drug Therapy; Ganglioneuroma; Gastroin | 1965 |
FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.
Topics: Aging; Busulfan; Cataract; Female; Humans; Leukemia; Leukemia, Myeloid; Longevity; Lung Neoplasms; L | 1965 |
EXPECTANCY FOR LIFE IN CHRONIC LYMPHATIC LEUKEMIA.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agents; Child; Chlorambucil; Cyclophospha | 1965 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu | 1965 |
[Combination of microdosage of chloralkylamines with roentgen irradiation in the treatment of hemoblastoses and hemoblastomas].
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphatic Vessels; Mechlorethamine | 1952 |
Treatment of malignant lymphomas and lymphadenoses with leukeran.
Topics: Chlorambucil; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Nitrogen Mus | 1959 |
CB 1348 therapy in leukemia and allied diseases.
Topics: Arylsulfonates; Chlorambucil; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
New nitrogen mustards in the control of leukemia.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1959 |
Clinical evaluation of the effect of degranol.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mannitol; Mannomustine; Mechlorethamine; | 1959 |
[Comparative studies on the effect of dimethanesulfonyl-D-mannitol and mannitol mustard on animal leukemia].
Topics: Leukemia; Leukemia, Experimental; Mannitol; Mannomustine; Mechlorethamine; Nitrogen Mustard Compound | 1962 |
Uracil mustard therapy in acute leukemia in children.
Topics: Acute Disease; Child; Infant; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Uracil Mustard | 1962 |
Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364.
Topics: Antineoplastic Agents; Chlorambucil; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Mechlo | 1962 |
Current control of the chronic leukemias with nitrogen mustards.
Topics: Chronic Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1961 |
Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; | 1962 |
Nitrogen mustards in the treatment of neoplastic disease.
Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis | 1950 |
[Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoidosis; Uret | 1950 |
[Nitrogen mustard therapy of malignant tumors].
Topics: Carcinoma; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1950 |
Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.
Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
Chemotherapy of leukemia. III. Further studies on the effect of nitrogen mustards and related compounds on transmitted mouse leukemia.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Clinical experiences with nitrogen mustards].
Topics: Erythema; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1951 |
[Chloronaphthylamine in the treatment of malignant lymphogranuloma and chronic leukemia].
Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1950 |
[Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
Topics: Amines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas | 1951 |
[Multiple successive and simultaneous treatment in a case of chronic myeloid leukemia].
Topics: Chloramines; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Mechlore | 1951 |
[Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compou | 1951 |
The principles of radiation therapy of lymphoblastoma.
Topics: Hodgkin Disease; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco | 1951 |
[Preliminary results of combined urethane, nitrogen mustard and Delbet's vaccine therapy of chronic myelocytic leukemias].
Topics: Humans; Immunotherapy, Active; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, | 1951 |
Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit | 1951 |
Precipitous leucopenia in a N-mustard treated leukemia; (an autopsy case).
Topics: Autopsy; Humans; Leukemia; Leukemia, Myeloid; Leukopenia; Mechlorethamine; Mustard Plant; Nitrogen M | 1951 |
[Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms].
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds | 1951 |
[Chloroalkylamines and acute leukemia; clinical and histopathological study of methyl-bis (beta chloroethyl) amine hydrochloride in acute hemocytoblastic leukosis].
Topics: Amines; Humans; Leukemia; Leukocytes; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
Chemotherapy in the reticuloses.
Topics: Leukemia; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Peptide Nucleic Acids; Phosphorus; | 1952 |
[Treatment of malignant lymphogranuloma and chronic leukemia with chloroethylnaphthylamine].
Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1951 |
[Treatment of leukemia with urethane and nitrogen mustards].
Topics: Humans; Leukemia; Leukemia, Myeloid; Mechlorethamine; Nitrogen Mustard Compounds; Urethane | 1951 |
Alkylamines in the treatment of leukaemia.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1952 |
[Problems of leucocyte metabolism. III. Effects of nitrogen mustard and nitrogen mustard in combination with urethan on the metabolism of cells of myeloid leukemia].
Topics: Humans; Leukemia; Leukemia, Myeloid; Leukocytes; Mechlorethamine; Nitrogen Mustard Compounds; Uretha | 1952 |
Leukemic lymphosarcoma, lymphosarcomatosis; remarkable but transitory efficiency of the nitrided perite.
Topics: Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1949 |
On treatment of spontaneous leukemia in mice with nitrogenized mustard gas.
Topics: Animals; Leukemia; Mechlorethamine; Mice; Mustard Gas; Nitrogen Mustard Compounds | 1950 |
[Action of chloramine in two cases of leukemic myelosis and in a case of malignant lymphogranuloma].
Topics: Chloramines; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.
Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; | 1950 |
The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias.
Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma | 1950 |
[Malignant growth and pharmacotherapy].
Topics: Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma; Urethane | 1950 |
Nitrogen Mustards in Fowl Leucosis.
Topics: Animals; Birds; Humans; Leukemia; Meat; Mechlorethamine; Nitrogen Mustard Compounds | 1948 |
The nitrogen mustards in the treatment of leukemia.
Topics: Ethylamines; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
Topics: Amines; Ethylamines; Hodgkin Disease; Humans; Leukemia; Lung Diseases; Lung Neoplasms; Lymphoma; Lym | 1949 |
Nitrogen mustard in treatment of leukemias.
Topics: Leukemia; Mechlorethamine; Nitrogen Mustard Compounds | 1949 |
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Bleomycin; Child; Child, Preschool; Daca | 1982 |
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne | 1984 |
[Various disputable problems of ambulatory treatment of tumors of the blood system].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Hodgkin | 1984 |
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1984 |
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 1984 |
[Acute leukemias and solid tumors in the course of Hodgkin disease].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1983 |
Second malignancy complicating Hodgkin's disease.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycloph | 1983 |
Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
Topics: Acute Disease; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1983 |
[10 years of DeVita protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1982 |
[The current state of curability of Hodgkin's disease].
Topics: Chromosome Aberrations; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamin | 1981 |
2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.
Topics: Cladribine; Cytarabine; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leuk | 1993 |
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Co | 1994 |
Differential inhibition of the DNA binding of transcription factors NF kappa B and OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional implications.
Topics: Base Composition; Base Sequence; Chloramphenicol O-Acetyltransferase; DNA-Binding Proteins; HIV Long | 1993 |
Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells.
Topics: Alkylating Agents; Animals; Blotting, Southern; Blotting, Western; Bone Marrow Transplantation; Chlo | 1996 |
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; | 1998 |
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hosp
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; F | 2001 |
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 2001 |
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz | 2002 |
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; | 1977 |
Hematologic neoplasia in patients treated for Hodgkin's disease.
Topics: Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechloreth | 1977 |
Drug-induced stimulation of transport of hydrolyzed nitrogen mustard and choline by normal and leukemic human cells in vitro.
Topics: Biological Transport; Choline; Cocaine; Dose-Response Relationship, Drug; In Vitro Techniques; Leuke | 1976 |
Hodgkin's disease and acute leukemia. Is it a true association?
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil | 1992 |
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1992 |
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues.
Topics: Cell Survival; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Ethacrynic Acid; Human | 1990 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci | 1991 |
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease | 1988 |
[Acute leukemia in patients treated for Hodgkin's disease].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Human | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali | 1988 |
Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colony-Forming Units Assay; D | 1987 |
[Myelodysplastic syndromes: a group of preleukemic disorders].
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia | 1987 |
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; | 1987 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Prot | 1985 |
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Diseas | 1973 |
[Cytostatic effects on nucleic acid- and protein synthesis of benign and malignant lymphomas].
Topics: Amides; Antineoplastic Agents; Dactinomycin; DNA, Neoplasm; Hodgkin Disease; Humans; Hydralazine; In | 1967 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C | 1973 |
Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera.
Topics: Antineoplastic Agents; Blood Bactericidal Activity; Carmustine; Cell Membrane; Complement System Pro | 1974 |
Combination chemotherapy of acute leukemia and Hodgkin's disease.
Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Predni | 1972 |
RNA metabolism in normal and leukaemic leucocytes: further studies on RNA synthesis.
Topics: Antimetabolites; Busulfan; Carbon Isotopes; Chromatography; Humans; Leukemia; Leukemia, Lymphoid; Le | 1968 |
[Results and current biological bases of therapy of malignant hemoreticulopathies].
Topics: Antineoplastic Agents; Chlorambucil; Cortisone; Cyclophosphamide; Humans; Hydrazines; Leukemia; Lymp | 1971 |
The use of combination therapy in leukemia remission.
Topics: Adolescent; Antineoplastic Agents; Central Nervous System Diseases; Child; Dactinomycin; Humans; Leu | 1969 |
Drugs and their abuse no. V--misuse of cytotoxic drugs.
Topics: Antineoplastic Agents; Cyclophosphamide; Fluorouracil; Humans; Leukemia; Mechlorethamine; Melphalan; | 1971 |
Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
Topics: Adult; Antineoplastic Agents; Busulfan; Chlorambucil; Hodgkin Disease; Humans; Leukemia; Lymphoma; M | 1968 |